These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8954850)

  • 21. Mouse Models of Alzheimer's Disease.
    Esquerda-Canals G; Montoliu-Gaya L; Güell-Bosch J; Villegas S
    J Alzheimers Dis; 2017; 57(4):1171-1183. PubMed ID: 28304309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Awareness disorders in Alzheimer's disease and in mild cognitive impairment].
    Jacus JP; Dupont MP; Herades Y; Pelix C; Large H; Baud M
    Encephale; 2014 Apr; 40(2):180-7. PubMed ID: 24630532
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Zebrafish as a tool in Alzheimer's disease research.
    Newman M; Verdile G; Martins RN; Lardelli M
    Biochim Biophys Acta; 2011 Mar; 1812(3):346-52. PubMed ID: 20920580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transgenic mice as a model for Alzheimer's disease.
    Lithner CU; Hedberg MM; Nordberg A
    Curr Alzheimer Res; 2011 Dec; 8(8):818-31. PubMed ID: 21592052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rodent models for Alzheimer's disease drug discovery.
    Puzzo D; Gulisano W; Palmeri A; Arancio O
    Expert Opin Drug Discov; 2015 Jul; 10(7):703-11. PubMed ID: 25927677
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanical stress models of Alzheimer's disease pathology.
    Levy Nogueira M; Epelbaum S; Steyaert JM; Dubois B; Schwartz L
    Alzheimers Dement; 2016 Mar; 12(3):324-33. PubMed ID: 26718585
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Review of Amyotrophic Lateral Sclerosis, Parkinson's and Alzheimer's diseases helps further define pathology of the novel paradigm for Alzheimer's with heavy metals as primary disease cause.
    Cavaleri F
    Med Hypotheses; 2015 Dec; 85(6):779-90. PubMed ID: 26604027
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Revisiting rodent models: Octodon degus as Alzheimer's disease model?
    Steffen J; Krohn M; Paarmann K; Schwitlick C; Brüning T; Marreiros R; Müller-Schiffmann A; Korth C; Braun K; Pahnke J
    Acta Neuropathol Commun; 2016 Aug; 4(1):91. PubMed ID: 27566602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of astrocyte reactivity improves functional deficits in mouse models of Alzheimer's disease.
    Ceyzériat K; Ben Haim L; Denizot A; Pommier D; Matos M; Guillemaud O; Palomares MA; Abjean L; Petit F; Gipchtein P; Gaillard MC; Guillermier M; Bernier S; Gaudin M; Aurégan G; Joséphine C; Déchamps N; Veran J; Langlais V; Cambon K; Bemelmans AP; Baijer J; Bonvento G; Dhenain M; Deleuze JF; Oliet SHR; Brouillet E; Hantraye P; Carrillo-de Sauvage MA; Olaso R; Panatier A; Escartin C
    Acta Neuropathol Commun; 2018 Oct; 6(1):104. PubMed ID: 30322407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Streptozotocin Intracerebroventricular-Induced Neurotoxicity and Brain Insulin Resistance: a Therapeutic Intervention for Treatment of Sporadic Alzheimer's Disease (sAD)-Like Pathology.
    Kamat PK; Kalani A; Rai S; Tota SK; Kumar A; Ahmad AS
    Mol Neurobiol; 2016 Sep; 53(7):4548-62. PubMed ID: 26298663
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Practical development of genetically engineered animals as human disease models.
    Nomura T
    Lab Anim Sci; 1997 Apr; 47(2):113-7. PubMed ID: 9150486
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human Alzheimer's disease gene expression signatures and immune profile in APP mouse models: a discrete transcriptomic view of Aβ plaque pathology.
    Rothman SM; Tanis KQ; Gandhi P; Malkov V; Marcus J; Pearson M; Stevens R; Gilliland J; Ware C; Mahadomrongkul V; O'Loughlin E; Zeballos G; Smith R; Howell BJ; Klappenbach J; Kennedy M; Mirescu C
    J Neuroinflammation; 2018 Sep; 15(1):256. PubMed ID: 30189875
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular mechanisms for Alzheimer's disease: implications for neuroimaging and therapeutics.
    Masters CL; Cappai R; Barnham KJ; Villemagne VL
    J Neurochem; 2006 Jun; 97(6):1700-25. PubMed ID: 16805778
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of human-like extracellular sortilin neuropathology in transgenic Alzheimer's disease model mice and macaques.
    Zhou FQ; Jiang J; Griffith CM; Patrylo PR; Cai H; Chu Y; Yan XX
    Alzheimers Res Ther; 2018 Apr; 10(1):40. PubMed ID: 29690919
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transgenic nonhuman primate models for human diseases: approaches and contributing factors.
    Chen Y; Niu Y; Ji W
    J Genet Genomics; 2012 Jun; 39(6):247-51. PubMed ID: 22749011
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single and multiple transgenic mice as models for Alzheimer's disease.
    van Leuven F
    Prog Neurobiol; 2000 Jun; 61(3):305-12. PubMed ID: 10727777
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generation of genetically altered mouse models for aging studies.
    Treuting PM; Hopkins HC; Ware CA; Rabinovitch PR; Ladiges WC
    Exp Mol Pathol; 2002 Feb; 72(1):49-55. PubMed ID: 11784122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Therapeutic strategies and Alzheimer's disease: contribution of animal models].
    Chabrier PE
    Ann Pharm Fr; 2009 Mar; 67(2):97-103. PubMed ID: 19298893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Commentary to the recently published review "Drug pipeline in neurodegeneration based on transgenic mice models of Alzheimer's disease" by Li, Evrahimi and Schluesener. Ageing Res. Rev. 2013 Jan;12(1):116-40.
    Windisch M; Flunkert S; Havas D; Hutter-Paier B
    Ageing Res Rev; 2013 Sep; 12(4):852-4. PubMed ID: 23851053
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Using animal models to determine the significance of complement activation in Alzheimer's disease.
    Loeffler DA
    J Neuroinflammation; 2004 Oct; 1(1):18. PubMed ID: 15479474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.